Andrew Getahun

2.3k total citations
49 papers, 1.7k citations indexed

About

Andrew Getahun is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Andrew Getahun has authored 49 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology, 17 papers in Molecular Biology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Andrew Getahun's work include T-cell and B-cell Immunology (25 papers), Immune Cell Function and Interaction (21 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Andrew Getahun is often cited by papers focused on T-cell and B-cell Immunology (25 papers), Immune Cell Function and Interaction (21 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Andrew Getahun collaborates with scholars based in United States, Sweden and United Kingdom. Andrew Getahun's co-authors include John C. Cambier, Birgitta Heyman, Fredrik Hjelm, Yuval Yarkoni, Fredrik Carlsson, Mia J. Smith, Jörgen Dahlström, Sara Wernersson, Mikael C. I. Karlsson and Mark J. Shlomchik and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Andrew Getahun

48 papers receiving 1.7k citations

Peers

Countries citing papers authored by Andrew Getahun

Since Specialization

Citations

This map shows the geographic impact of Andrew Getahun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Getahun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Getahun more than expected).

Fields of papers citing papers by Andrew Getahun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Getahun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Getahun. The network helps show where Andrew Getahun may publish in the future.

Co-authorship network of co-authors of Andrew Getahun

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Getahun. A scholar is included among the top collaborators of Andrew Getahun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Getahun. Andrew Getahun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Allergens abrogate antiinflammatory DNA effects and unmask macrophage-driven neutrophilic asthma via ILC2/STING/TNF-α signaling 2025 ·Journal of Clinical Investigation ·Anand Sripada, (unknown), (unknown), Kapil Sirohi, (unknown), (unknown), Mukesh Verma, Anita Sahu, Vamsi P. Guntur, (unknown), Brian Vestal, Camille M. Moore, Richard J. Martin, Magdalena M. Gorska, John C. Cambier, Andrew Getahun, Rafeul Alam	0
2	Interleukin-1 signaling and CD4+ T cells control B cell recruitment to the lungs in chronic beryllium disease 2025 ·Frontiers in Immunology ·(unknown), (unknown), Douglas G. Mack, (unknown), (unknown), Tabrez A. Mohammad, Arlan D. Martin, Andrew Getahun, Charles A. Dinarello, Andrew P. Fontenot, Shaikh M. Atif	1
3	Preclinical Analysis of Candidate Anti-Human CD79 Therapeutic Antibodies Using a Humanized CD79 Mouse Model 2022 ·The Journal of Immunology ·Scott M. Wemlinger, Chelsea R. Parker Harp, Bo Yu, Ian R. Hardy, (unknown), Jennifer L. Matsuda, Michaël Mingueneau, Kerri Spilker, Thomas O. Cameron, James W. Larrick, Andrew Getahun, John C. Cambier	8
4	Inhibitory Receptor Trap: A Platform for Discovery of Inhibitory Receptors That Utilize Inositol Lipid and Phosphotyrosine Phosphatase Effectors 2020 ·Frontiers in Immunology ·(unknown), (unknown), Vanessa Ott, Isaac T. W. Harley, Andrew Getahun, John C. Cambier	6
5	Protective role of B cells in sterile particulate–induced lung injury 2019 ·JCI Insight ·Shaikh M. Atif, Douglas G. Mack, Amy S. McKee, Javier Rangel‐Moreno, Arlan D. Martin, Andrew Getahun, Lisa A. Maier, John C. Cambier, Rubin M. Tuder, Andrew P. Fontenot	14
6	γδ T cells shape memory-phenotype αβ T cell populations in non-immunized mice 2019 ·PLoS ONE ·(unknown), Yafei Huang, Kira Rubtsova, Andrew Getahun, Deming Sun, R. Lee Reinhardt, Rebecca L. O’Brien, Willi K. Born	6
7	A Precision B Cell–Targeted Therapeutic Approach to Autoimmunity Caused by Phosphatidylinositol 3-Kinase Pathway Dysregulation 2019 ·The Journal of Immunology ·S. Elizabeth Franks, Andrew Getahun, John C. Cambier	12
8	Elevated PTEN expression maintains anergy in human B cells and reveals unexpectedly high repertoire autoreactivity 2019 ·JCI Insight ·Mia J. Smith, B. Rhodes Ford, Marynette Rihanek, (unknown), Andrew Getahun, Virginia D. Sarapura, (unknown), John C. Cambier	45
9	B Cell–Intrinsic STING Signaling Triggers Cell Activation, Synergizes with B Cell Receptor Signals, and Promotes Antibody Responses 2018 ·The Journal of Immunology ·(unknown), (unknown), John C. Cambier, Andrew Getahun	52
10	Impaired B cell function during viral infections due to PTEN-mediated inhibition of the PI3K pathway 2017 ·The Journal of Experimental Medicine ·Andrew Getahun, Scott M. Wemlinger, Pratyaydipta Rudra, Mario L. Santiago, Linda F. van Dyk, John C. Cambier	24
11	Targeting B cells in treatment of autoimmunity 2016 ·Current Opinion in Immunology ·S. Elizabeth Franks, Andrew Getahun, P. Mark Hogarth, John C. Cambier	48
12	Of ITIM s, ITAM s, and ITAM is: revisiting immunoglobulin Fc receptor signaling 2015 ·Immunological Reviews ·Andrew Getahun, John C. Cambier	110
13	Phosphatase regulation of immunoreceptor signaling in T cells, B cells and mast cells 2013 ·Current Opinion in Immunology ·(unknown), Andrew Getahun, John C. Cambier, Marc Daëron	12
14	Complement Receptors 1 and 2 in Murine Antibody Responses to IgM-Complexed and Uncomplexed Sheep Erythrocytes 2012 ·PLoS ONE ·(unknown), (unknown), Andrew Getahun, Jenny Hallgren, Frida Henningsson, Birgitta Heyman	27
15	Molecular underpinning of B‐cell anergy 2010 ·Immunological Reviews ·Yuval Yarkoni, Andrew Getahun, John C. Cambier	89
16	IgE Enhances Antibody and T Cell Responses In Vivo via CD23+ B Cells 2005 ·The Journal of Immunology ·Andrew Getahun, Fredrik Hjelm, Birgitta Heyman	73
17	Identification of the causative organism of tuberculosis lymphadenitis in Ethiopia by PCR 2004 ·(unknown), Joseph Olobo, (unknown), (unknown), (unknown), Andrew Getahun, (unknown), (unknown), M Harboe	3
18	IgG2a-Mediated Enhancement of Antibody and T Cell Responses and Its Relation to Inhibitory and Activating Fcγ Receptors 2004 ·The Journal of Immunology ·Andrew Getahun, Jörgen Dahlström, Sara Wernersson, Birgitta Heyman	77
19	FcγRIIB in IgG-Mediated Suppression of Antibody Responses: Different Impact In Vivo and In Vitro 2001 ·The Journal of Immunology ·Mikael C. I. Karlsson, Andrew Getahun, Birgitta Heyman	54
20	Graded retinoid responses in the developing hindbrain 1998 ·Developmental Dynamics ·Susan F. Godsave, C. H. Koster, Andrew Getahun, (unknown), (unknown), Jacqueline van der Wees, Jan Hendriks, Antony J. Durston	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact